The Pfizer logo is displayed at the company’s headquarters in New York. Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death by nearly 90% among patients with mild-to-moderate infections. Mark Lennihan/AP hide caption toggle caption Mark Lennihan/AP The Pfizer logo is displayed at the company’s headquarters in New York. Pfizer says…